Article
Metabolic and Nutritional Support of the Enterocutaneous Fistula Patient: A Three-Phase Approach
Travis M. Polk,
C. William Schwab,
Corresponding Author
Travis M. Polk
Division of Traumatology, Surgical Critical Care, and Emergency Surgery, University of Pennsylvania, Philadelphia, PA, USA
[email protected]Search for more papers by this authorC. William Schwab
Division of Traumatology, Surgical Critical Care, and Emergency Surgery, University of Pennsylvania, Philadelphia, PA, USA
Search for more papers by this authorTravis M. Polk,
C. William Schwab,
Corresponding Author
Travis M. Polk
Division of Traumatology, Surgical Critical Care, and Emergency Surgery, University of Pennsylvania, Philadelphia, PA, USA
[email protected]Search for more papers by this authorC. William Schwab
Division of Traumatology, Surgical Critical Care, and Emergency Surgery, University of Pennsylvania, Philadelphia, PA, USA
Search for more papers by this authorAbstract
Background
The care and outcome of enterocutaneous fistula (ECF) have improved greatly over several decades due to revolutionary advances in nutrition, along with dramatic improvements in the treatment of sepsis and the critically ill. However, as the collective experience with damage control surgery has matured, the frequent development of enteroatmospheric fistula (EAF) in the “open abdomen” patient has emerged as an even more vexing problem. Despite our best efforts, ECF and especially EAF continue to be highly morbid conditions, and sepsis and malnutrition remain the leading causes of death. Aggressive nutritional and metabolic support is the most significant predictor of outcome with ECF and EAF.
Results
Discussion of the historical advances in nutritional therapy and their impact on ECF, as well as review of the classification of ECF and EAF, provides a framework for the suggested phased strategy that specifically targets the nutritional and metabolic needs of the ECF/EAF patient. These three phases include (1) diagnosis, resuscitation, and early interval nutrition; (2) definition of fistula anatomy, drainage of collections, nutritional assessment and monitoring, and placement of feeding access; and (3) definitive nutritional management, including pharmacologic adjuncts. Early nutritional support with parenteral nutrition followed by transition to enteral nutrition is advocated, including the merits of delivery of enteral nutrition via the fistula itself, known as fistuloclysis.
Conclusion
Aggressive nutritional therapy is necessary to reverse the catabolic state associated with ECF/EAF patients. Once established, it allows proper time, preparation, and planning for definitive management of the fistula, and in many cases provides the support for spontaneous closure.
References
- 1Bhishagratna KK (trans) (1907) An English translation of The Sushruta Samhita: based on original Sanskrit text. Wilkens Press, Calcutta. Available at http://www.archive.org/stream/englishtranslati01susruoft#page/n23/mode/2up/search/ant Accessed 1 Feb 2011
- 2SarrMG, BassP, WoodwardE The famous gastrocutaneous fistula of Alexis st. MartinߝWhy didn’t it close? Or should we refer to it as a gastric stoma?. Dig Dis Sci (1991) 36(10): 1345–1347191475310.1007/BF01296797
- 3ColpR External duodenal fistulae. Ann Surg (1923) 78: 725–7441786494110.1097/00000658-192312000-00004
- 4EdmundsLH, WilliamsGM, WelchCE External fistulas arising from the gastro-intestinal tract. Ann Surg (1960) 152: 445–4711372574210.1097/00000658-196009000-00009
- 5ChapmanR, ForanR et al. Management of intestinal fistula. Am J Surg (1964) 108: 974–98410.1016/0002-9610(64)90005-4
- 6LundyJB, FischerJE Historical perspectives in the care of patients with enterocutaneous fistula. Clin Colon Rectal Surg (2010) 23: 133–1412188646210.1055/s-0030-1262980
- 7HullHC, BarnesTG Total intravenous alimentation in the treatment of small bowel fistulas. Ann Surg (1951) 133(5): 644–6501483013410.1097/00000658-195105000-00007
- 8DudrickSJ, WilmoreDW, VarsHM, RhoadsJE Can intravenous feeding as the sole means of nutrition support growth in the child and restore weight loss in an adult? An affirmative answer. Ann Surg (1969) 169: 974–984497696010.1097/00000658-196906000-00018
- 9SchecterWP, HirshbergA, ChangDS et al. Enteric fistula: principles of management. J Am Coll Surg (2009) 209(4): 484–4911980132210.1016/j.jamcollsurg.2009.05.025
- 10ArebiN, ForbesA High output fistulas. Clin Colon Rectal Surg (2004) 17(2): 89–982001125310.1055/s-2004-828655
- 11FenvesAZ, EmmettM JP O’Leary Fluid and electrolytes. The physiologic basis of surgery (1996) 2BaltimoreWilliams and Willams
- 12BerrySM, FischerJE Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am (1996) 76: 1009–1018884136110.1016/S0039-6109(05)70495-3
- 13RotondoMF, SchwabCW, McGonigalMD et al. Damage control: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma (1983) 35(3): 375–38310.1097/00005373-199309000-00008
10.1097/00005373-199309000-00008 Google Scholar
- 14JacobsS, Price EvansDA et al. Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med (2003) 31: 1938–19461284738610.1097/01.CCM.0000074724.71242.88
- 15DellingerRP, LevyMM, CarletJM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med (2008) 36: 296–3271815843710.1097/01.CCM.0000298158.12101.41Erratum 36:1394–1396
- 16LeeJK, SteinSL Radiographic and endoscopic diagnosis and treatment of enterocutaneous fistulas. Clin Colon Rectal Surg (2010) 23: 149–1602188646410.1055/s-0030-1262982
- 17DudrickSJ, MaharajAR, McKelveyAA Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg (1999) 23: 570–5761022792610.1007/PL00012349
- 18WilliamsLJ, ZolfaghariS, BousheyRP Complications of enterocutaneous fistulas and their management. Clin Colon Rectal Surg (2010) 23: 209–2202188647110.1055/s-0030-1263062
- 19HoedemaRE, SuryadevaraS Enterostomal therapy and wound care of the enterocutaneous fistula patient. Clin Colon Rectal Surg (2010) 23: 161–1682188646510.1055/s-0030-1262983
- 20EvensonAR, FischerJE Current management of enterocutaneous fistula. J Gastrointestinal Surg (2006) 10(3): 455–46410.1016/j.gassur.2005.08.001
- 21CheathamML, SafcsakK, BrzezinskiSJ et al. Nitrogen balance, protein loss, and the open abdomen. Crit Care Med (2007) 35(1): 127–1311709594010.1097/01.CCM.0000250390.49380.94
- 22 Nutrition Advisory Committee (1997) Clinical nutrition: a resource book for delivering enteral and parenteral nutrition for adults, University of Washington Medical Center and Harborview Medical Center, Seattle. Available at http://healthlinks.washington.edu/nutrition/section7.html Accessed 6 Apr 2011
- 23GibbsJ, CullW, HendersonW et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg (1999) 134: 36–42992712810.1001/archsurg.134.1.36
- 24FazioVS, CoutsoftidesT, StiegerE Factors influencing outcome of treatment of small bowel cutaneous fistula. World J Surg (1983) 7: 481–488662412310.1007/BF01655937
- 25LuCY, WuDC, WuIC Serum albumin level in the management of postoperative enteric fistula for gastrointestinal cancer patients. J Invest Surg (2008) 21: 25–321819753110.1080/08941930701833959
- 26KuvshinoffBW, BrodishRJ, McFaddenDW et al. Serum transferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal fistula. Ann Surg (1993) 217(6): 615–622850711010.1097/00000658-199306000-00003
- 27LubanaPS, AggarwalG, AggarwalH et al. Serum transferrin levelsߝa predictive marker of spontaneous closure and mortality in patients with enterocutaneous fistulae. Arab J Gastroenterol (2010) 11: 212–21410.1016/j.ajg.2010.10.002
- 28BleirJI, HedrickT Metabolic support of the enterocutaneous fistula patient. Clin Colon Rectal Surg (2010) 23: 142–14810.1055/s-0030-1262981
- 29MacFadyenBV, DudrickSJ, RubergRI Management of gastrointestinal fistula with parenteral hyperalimentation. Surgery (1973) 74(1): 100–1054197679
- 30HimalHS, AllardJR, NadeaJE et al. The importance of adequate nutrition in closure of small intestinal fistulas. Br J Surg (1974) 61: 724–730421345010.1002/bjs.1800610913
- 31DeitelM Nutritional management of external gastrointestinal fistulas. Can J Surg (1976) 19: 505–509825210
- 32TilsonMD Pathophysiology of short bowel syndrome. Surg Clin North Am (1980) 60: 1273–12847434164
- 33LloydDA, GabeSM, WindsorAC Nutrition and management of enterocutaneous fistula. Brit J Surg (2006) 93: 1045–10551680487310.1002/bjs.5396
- 34DardaiE, PirityiSZ, NagyL Parenteral and enteral nutrition and the enterocutaneous fistula treatment II: factors influencing the outcome of patients. Acta Chir Hung (1991) 32(4): 305–3181844622
- 35LevyE, FileuxP, CugnencPH et al. High output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg (1989) 76: 676–679250443610.1002/bjs.1800760708
- 36LiJ, RenJ, ZhuW et al. Management of enterocutaneous fistulas: 30-year clinical experience. Chin Med J (2003) 116(2): 171–17512775223
- 37TeubnerA, MorrisonK, Ravishankar et al. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg (2004) 91: 625–6311512261610.1002/bjs.4520
- 38McClaveSA, MartindaleRG, VanekVW Guidelines for the provision of nutrition support therapy in the adult critically ill patient: Society for Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N). JPEN J Parenter Enteral Nutr (2009) 33: 277–3161939861310.1177/0148607109335234
- 39CollierB, GuillamondeguiO, CottonB et al. Feeding the open abdomen. JPEN J Parenter Enteral Nutr (2007) 31(5): 410–4151771215010.1177/0148607107031005410
- 40DissanaikeS, PhamT, ShalhubS et al. Effect of immediate enteral feeding on trauma patients with an open abdomen: protection from nosocomial infection. J Am Coll Surg (2008) 207(5): 690–6971895478110.1016/j.jamcollsurg.2008.06.332
- 41LevyEP, PalmerDL, FrileauxP et al. Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the distal small bowel: a clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg (1983) 198(5): 596–600641619110.1097/00000658-198311000-00006
- 42SlaterR Nutritional management of enterocutaneous fistula. Br J Nurs (2009) 18(4): 225–23019462583
- 43CresciGA, MartindaleRG Metabolic and nutritional management of a patient with multiple enterocutaneous fistulas. Nutrition (1997) 13: 446–449922533810.1016/S0899-9007(97)00094-4
- 44MettuSR Correspondence: fistuloclysis can replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg (2004) 91(9): 12031544927810.1002/bjs.4820
- 45FarrerK, TeubnerA Fistuloclysis-distal feeding handbook: information and guidance for patients and healthcare professionals (2003) ManchesterSalford Royal Hospital
- 46SubramaniamMH, LiscumKR, HirshbergA The floating stoma: a new technique for controlling exposed fistulae in abdominal trauma. J Trauma (2002) 53: 386–3881216995610.1097/00005373-200208000-00037
- 47Cawich SO, McFarlane ME, Mitchell DI (2007) Fistuloclysis: cost effective nutrition for patients with enterocutaneous fistulae. Internet J Third World Med 4(2)
- 48BuryKD, StephensRV, RandalHT Use of chemically defined, liquid, elemental diet for nutritional management of fistulas of the alimentary tract. Am J Surg (1971) 121(2): 174–183499322410.1016/0002-9610(71)90096-1
- 49HeysSD, WalkerLG, SmithI, EreminO Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg (1999) 229: 467–4771020307810.1097/00000658-199904000-00004
- 50BealeRJ, BrygDJ, BihariDJ Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med (1999) 27: 2799–28051062862910.1097/00003246-199912000-00032
- 51MartindaleRG, CresciGA The use of immune enhancing diet in head injury. JPEN J Parenter Enteral Nutr (2001) 25(2 Suppl): S27–S281128891910.1177/014860710102500207
- 52CerraFB, LehmanS, KonstantinidesN, KonstantinidesF, ShrontsEP, HolmanR Effect of enteral nutrient on in vitro tests of immune function in ICU patients: a preliminary report. Nutrition (1990) 6: 84–872135759
- 53GottschlichMM, JenkinsM, WardenGD et al. Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr (1990) 14: 225–236211263410.1177/0148607190014003225
- 54KingRF, NortonT, HillGI A double-blinded crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust NZ J Surg (1982) 52(2): 121–12410.1111/j.1445-2197.1982.tb06083.x
- 55NubiolaP, BadiaJM, Martinez-RodenasF et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201–995. Ann Surg (1989) 210: 56–58250090010.1097/00000658-198907000-00009
- 56BarnesSM, KontnyBG, PrinzRA Somatostatin analog treatment of pancreatic fistulas. Int J Pancreatol (1993) 14: 181–1888283081
- 57Nubiola-CalongeP, BadiaJM, SanchoJ, GilMJ, SeguraM, Sitges-SerraA Blind evaluation of the effect of octreotide (SMS 201–995), a somatostatin analogue, on small-bowel fistula output. Lancet (1987) 2: 672–674288795110.1016/S0140-6736(87)92452-4
- 58Hernandez-ArandaJC, Gallo-ChicoB, Flores-RamirezLA, Avalos-HuanteR, Magos-VazquezFJ, Ramirez-BarbaEJ Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition. Nutr Hosp (1996) 11: 226–2298962902
- 59CooperAM, BraatvedtGD, BrownH et al. Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man. Clin Sci (London) (1991) 81(2): 169–175
- 60HeuserM, PopkenO, KleimanI, PostS Detrimental effects of octreotide on intestinal microcirculation. J Surg Res (2000) 92(2): 186–1921089682010.1006/jsre.2000.5898
- 61KacmazA, PolatA, UserY et al. Octreotide improves reperfusion-induced oxidative injury in acute abdominal hypertension in rats. J Gastroint Surg (2004) 8(1): 113–11910.1016/j.gassur.2003.09.026
- 62MorrisJB, GuerreroNH, FurthEE, StellatoTA Somatostatin attenuates ischemic intestinal injury. Am J Surg (1993) 165(6): 676–680809947210.1016/S0002-9610(05)80786-X
